External validation of the ITA.LI.CA prognostic system for patients with hepatocellular carcinoma: A multicenter cohort studyMauro Borzio, Fabio Fornari, E. Dionigi et al.|Hepatology|2017Cited by 49
Four years of tenofovir monotherapy for NUC naïve field practice European patients suppresses HBV replication in most patients with a favorable renal safety profile but does not prevent HCC in patients with or without cirrhosisPietro Lampertico, M. Colombo, S. Zaltron et al.|Digestive and Liver Disease|2014Cited by 23
Management and prognosis of hepatocellular carcinoma in the elderly: Results of an in‐field multicenter cohort studyMauro Borzio, Rodolfo Sacco, E. Dionigi et al.|Liver International|2017Cited by 23
Trend of Improving Prognosis of Hepatocellular Carcinoma in Clinical Practice: An Italian In-Field ExperienceMauro Borzio, Rodolfo Sacco, Angelo Rossini et al.|Digestive Diseases and Sciences|2014Cited by 11